128 assets in Metabolic Dysfunction-Associated Steatohepatitis

Therapeutic assets addressing Metabolic Dysfunction-Associated Steatohepatitis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Kylo-0603 Metabolic Dysfunction-Associated Steatohepatitis	Kylonova (Xiamen) Biopharma co., LTD.	P1	CC (46)
Lb-P6 Metabolic Dysfunction-Associated Steatohepatitis	LISCure Biosciences	P1	CC (46)
Lb-P8 Metabolic Dysfunction-Associated Steatohepatitis	LISCure Biosciences	P1	CC (46)
ly3849891 Metabolic Dysfunction-Associated Steatohepatitis	Eli Lilly and Company	P1	CC (46)
oa-235i Metabolic Dysfunction-Associated Steatohepatitis	Oasis Pharmaceuticals, LLC	P1	CC (46)
Tvb-2640 - Metabolic Dysfunction-Associated Steatohepatitis	Sagimet Biosciences Inc.	P1	CC (46)
vk2735 Metabolic Dysfunction-Associated Steatohepatitis	Viking Therapeutics, Inc.	P1	CC (46)
Warfarin Metabolic Dysfunction-Associated Steatohepatitis	Altimmune, Inc.	P1	CC (46)
[14c]-rencofilstat Metabolic Dysfunction-Associated Steatohepatitis	Hepion Pharmaceuticals, Inc.	Early P1	CC (43)
bar502 Metabolic Dysfunction-Associated Steatohepatitis	BAR Pharmaceuticals s.r.l.	P1	CC (43)
cs060304 Metabolic Dysfunction-Associated Steatohepatitis	Cascade Pharmaceuticals, Inc	P1	CC (43)
dnp007 Metabolic Dysfunction-Associated Steatohepatitis	Seoul National University Hospital	P1	CC (43)
gm-60106 Metabolic Dysfunction-Associated Steatohepatitis	JD Bioscience Inc.	P1	CC (43)
Ini-822 Metabolic Dysfunction-Associated Steatohepatitis	Inipharm Australia Pty Ltd	P1	CC (43)
Moxifloxacin Metabolic Dysfunction-Associated Steatohepatitis	AstraZeneca	P1	CC (43)
ro7790121 Metabolic Dysfunction-Associated Steatohepatitis	Hoffmann-La Roche	P1	CC (43)
[68ga]ga-dota-cys-ath001 Metabolic Dysfunction-Associated Steatohepatitis	Antaros Medical	Early P1	C (39)
Huazhi Rougan Granule Metabolic Dysfunction-Associated Steatohepatitis	Nanjing First Hospital, Nanjing Medical University	N/A	D (30)
Lang Qingata Metabolic Dysfunction-Associated Steatohepatitis	Shupei Li	N/A	D (30)
Niacin Metabolic Dysfunction-Associated Steatohepatitis	Université de Sherbrooke	N/A	D (30)
b1344 Metabolic Dysfunction-Associated Steatohepatitis	Tasly Biopharmaceuticals Co., Ltd.	P1	NR ()
bi 770371 Metabolic Dysfunction-Associated Steatohepatitis	Boehringer Ingelheim	P2	NR ()
HEC169584 Metabolic Dysfunction-Associated Steatohepatitis	Sunshine Lake Pharma Co., Ltd.	P1	NR ()
Opk-88006 Metabolic Dysfunction-Associated Steatohepatitis	OPKO Health, Inc.	P1/2	NR ()
Pegozafermin Metabolic Dysfunction-Associated Steatohepatitis	89bio, Inc.	P3	NR ()
ql2401 Metabolic Dysfunction-Associated Steatohepatitis	Qilu Pharmaceutical Co., Ltd.	P2	NR ()
Snp-610 Metabolic Dysfunction-Associated Steatohepatitis	Sinew Pharma Inc.	P2	NR ()

Showing 101 to 128 of 128 assets

PreviousPage 3 of 3Next